June « 2014 « Science and Enterprise

Student Project Aims to Land Time Capsule on Mars

By Alan, on June 23rd, 2014%

Emily Briere, project mission director (A. Kotok)

23 June 2014. Students from four U.S. universities — with help from research labs, not-for-profit organizations, and companies — are building a space vehicle to propel and land a time capsule of digital files from earth on the surface of Mars. The Time Capsule to Mars . . . → Read More: Student Project Aims to Land Time Capsule on Mars

Early Trial Shows Pneumonia Vaccine Safety, Immune Response

By Alan, on June 23rd, 2014%

Pneumococcus colony (NIST.gov)

23 June 2014. An early-stage clinical trial testing a vaccine by Genocea Biosciences Inc. to prevent pneumonia and related bacterial diseases shows the vaccine caused no serious side effects and induced more immune system cells to prevent these infections. The Cambridge, Massachusetts biotechnology company says it plans to present the . . . → Read More: Early Trial Shows Pneumonia Vaccine Safety, Immune Response

Challenge Seeks Development Partner for Nanotech Biosensor

By Alan, on June 20th, 2014%

(Photos8.com)

20 June 2014. A new challenge on InnoCentive calls for a medical technology company or institute to develop a new type of nanoscale biosensor for diagnostic and therapeutic applications. The challenge has no immediate financial award, but winners of the competition will earn the right to negotiate a compensated collaboration contract with . . . → Read More: Challenge Seeks Development Partner for Nanotech Biosensor

U.K. Public-Private Partnership to Attack Dementia

By Alan, on June 20th, 2014%

(Research.gov)

20 June 2014. Medical Research Council, a science funding agency in the U.K., organized a consortium of academic and industry researchers to better detect, prevent, and treat dementia. The council and six industry partners plan to spend £16 million ($US 27.25 million) on the U.K. Dementias Research Platform that includes studies involving . . . → Read More: U.K. Public-Private Partnership to Attack Dementia

Foundation, Biopharm Partner on RNA-Interference Therapy

By Alan, on June 19th, 2014%

RNA illustration (Research.gov)

19 June 2014. Alnylam Pharmaceuticals Inc. in Cambridge, Massachusetts and the Alpha-1 Project in Miami are collaborating on advancing Alnylam’s therapy to treat alpha-1 antitrypsin deficiency, a rare genetic condition responsible for liver disorders and a lung disease similar to chronic obstructive pulmonary disease or COPD. Alpha-1 Project is the . . . → Read More: Foundation, Biopharm Partner on RNA-Interference Therapy

Lasers Embed Sensors in Smartphone Display Glass

By Alan, on June 19th, 2014%

Laser writing a waveguide into a smartphone display glass. (Optics Express)

19 June 2014. Engineers at École Polytechnique de Montréal and Corning Inc. in Corning, New York designed a process for embedding sensors into the display glass covers on smartphones. The research team led by doctoral candidate Jerome Lapointe published its findings in . . . → Read More: Lasers Embed Sensors in Smartphone Display Glass

Portfolio Model Proposed for Funding Alzheimer’s Research

By Alan, on June 18th, 2014%

(National Institute of Drug Abuse)

18 June 2014. Financial and biomedical researchers at Massachusetts Institute of Technology, University of California in Santa Barbara, and the biotechnology company Genentech outlined a different approach to funding research on Alzheimer’s disease that supports multiple simultaneous studies addressing various drug targets. The team led by MIT finance . . . → Read More: Portfolio Model Proposed for Funding Alzheimer’s Research

FDA Issues Draft Industry Guidance on Social Media

By Alan, on June 18th, 2014%

(Wikimedia Commons)

18 June 2014. The U.S. Food and Drug Administration issued draft guidance for medical products companies on their use of social media to communicate with patients. The agency announced yesterday the documents’ availability for comment in a blog post authored by Thomas Abrams, director of FDA’s prescription drug information office.

Abrams . . . → Read More: FDA Issues Draft Industry Guidance on Social Media

Fibrocell Science Licenses Stem Cell Technology from UCLA

By Alan, on June 17th, 2014%

Fibroblast (Heiti Paves, Wikimedia Commons)

17 June 2014. The biotechnology company Fibrocell Science Inc. in Exton, Pennsylvania is licensing stem cell discoveries from University of California in Los Angeles for personalized treatments of serious bone and connective tissue conditions. Financial aspects of the licensing deal were not disclosed.

Fibrocell Science develops treatments for . . . → Read More: Fibrocell Science Licenses Stem Cell Technology from UCLA

Code Language Developed for Building Lab-On-Chip Devices

By Alan, on June 17th, 2014%

Microfluidic chip (Sandia National Lab)

17 June 2014. Engineers at University of California in Riverside developed a programming language to automate the design of lab-on-a-chip devices used in medical diagnostics and other life science applications. The team from the lab of computer science and engineering professor Philip Brisk published its results in a . . . → Read More: Code Language Developed for Building Lab-On-Chip Devices

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise